| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Corpus Striatum | 55 | 2014 | 279 | 7.230 |
Why?
|
| Amphetamine | 26 | 2011 | 77 | 5.230 |
Why?
|
| Brain-Derived Neurotrophic Factor | 18 | 2018 | 124 | 5.190 |
Why?
|
| Cocaine | 24 | 2018 | 555 | 4.100 |
Why?
|
| Cocaine-Related Disorders | 13 | 2017 | 504 | 3.190 |
Why?
|
| Drug-Seeking Behavior | 10 | 2018 | 213 | 3.160 |
Why?
|
| Prefrontal Cortex | 18 | 2018 | 640 | 3.110 |
Why?
|
| Dynorphins | 49 | 2008 | 69 | 3.020 |
Why?
|
| Central Nervous System Stimulants | 15 | 2015 | 221 | 2.920 |
Why?
|
| RNA, Messenger | 47 | 2010 | 1664 | 2.890 |
Why?
|
| Protein Precursors | 38 | 2008 | 105 | 2.680 |
Why?
|
| Gene Expression Regulation | 22 | 2013 | 1293 | 2.430 |
Why?
|
| Neuropeptides | 15 | 2007 | 106 | 2.380 |
Why?
|
| Rats | 111 | 2018 | 5300 | 2.250 |
Why?
|
| Nucleus Accumbens | 16 | 2018 | 417 | 2.180 |
Why?
|
| Rats, Sprague-Dawley | 35 | 2018 | 2083 | 2.040 |
Why?
|
| Neostriatum | 14 | 2009 | 60 | 1.940 |
Why?
|
| Behavior, Animal | 25 | 2011 | 470 | 1.920 |
Why?
|
| Methamphetamine | 12 | 2015 | 132 | 1.920 |
Why?
|
| Enkephalins | 36 | 2006 | 89 | 1.880 |
Why?
|
| Nerve Tissue Proteins | 14 | 2018 | 290 | 1.860 |
Why?
|
| Neurons | 22 | 2018 | 881 | 1.850 |
Why?
|
| Dopamine Uptake Inhibitors | 11 | 2018 | 152 | 1.800 |
Why?
|
| Animals | 147 | 2022 | 20881 | 1.770 |
Why?
|
| Central Nervous System Agents | 4 | 2017 | 37 | 1.650 |
Why?
|
| Self Administration | 23 | 2018 | 419 | 1.620 |
Why?
|
| Glutamic Acid | 13 | 2016 | 332 | 1.510 |
Why?
|
| Cerebral Cortex | 12 | 2018 | 415 | 1.490 |
Why?
|
| Substance Withdrawal Syndrome | 8 | 2016 | 435 | 1.490 |
Why?
|
| Hippocampus | 33 | 2011 | 471 | 1.360 |
Why?
|
| RGS Proteins | 4 | 2011 | 22 | 1.260 |
Why?
|
| Dopamine | 14 | 2012 | 474 | 1.230 |
Why?
|
| Immediate-Early Proteins | 10 | 2002 | 63 | 1.180 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 8 | 2017 | 175 | 1.080 |
Why?
|
| Rats, Wistar | 33 | 2018 | 371 | 1.070 |
Why?
|
| Gene Expression | 14 | 2018 | 770 | 1.060 |
Why?
|
| Motor Activity | 13 | 2010 | 621 | 1.060 |
Why?
|
| Receptors, Dopamine D1 | 9 | 2010 | 87 | 1.060 |
Why?
|
| Male | 110 | 2018 | 37321 | 1.050 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 2 | 2017 | 3 | 1.030 |
Why?
|
| Cytoskeletal Proteins | 5 | 2018 | 108 | 0.990 |
Why?
|
| Receptors, Dopamine D2 | 8 | 2010 | 109 | 0.980 |
Why?
|
| Phosphorylation | 14 | 2018 | 1200 | 0.960 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 8 | 2017 | 266 | 0.940 |
Why?
|
| Receptors, AMPA | 8 | 2014 | 99 | 0.930 |
Why?
|
| Transcription Factors | 11 | 2000 | 753 | 0.920 |
Why?
|
| Proto-Oncogene Proteins c-fos | 10 | 2018 | 114 | 0.920 |
Why?
|
| In Situ Hybridization | 22 | 2008 | 201 | 0.920 |
Why?
|
| Receptors, Metabotropic Glutamate | 5 | 2011 | 75 | 0.910 |
Why?
|
| Prosencephalon | 7 | 2006 | 38 | 0.880 |
Why?
|
| Receptors, Dopamine | 6 | 2010 | 119 | 0.850 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 5 | 2018 | 39 | 0.850 |
Why?
|
| DNA-Binding Proteins | 10 | 2000 | 700 | 0.840 |
Why?
|
| Neural Pathways | 8 | 2018 | 324 | 0.810 |
Why?
|
| Early Growth Response Protein 1 | 12 | 2010 | 42 | 0.800 |
Why?
|
| Substantia Nigra | 9 | 2010 | 102 | 0.790 |
Why?
|
| Endorphins | 18 | 1994 | 32 | 0.720 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 4 | 2010 | 52 | 0.720 |
Why?
|
| Amygdala | 8 | 2010 | 159 | 0.710 |
Why?
|
| Oxytocin | 3 | 2017 | 124 | 0.700 |
Why?
|
| Amphetamine-Related Disorders | 4 | 2009 | 92 | 0.690 |
Why?
|
| Dendritic Spines | 2 | 2018 | 76 | 0.680 |
Why?
|
| Synaptic Transmission | 5 | 2016 | 236 | 0.680 |
Why?
|
| Neuronal Plasticity | 3 | 2018 | 274 | 0.680 |
Why?
|
| Benzazepines | 8 | 2010 | 104 | 0.660 |
Why?
|
| Pyrrolidines | 7 | 1999 | 45 | 0.650 |
Why?
|
| Brain | 11 | 2014 | 2176 | 0.620 |
Why?
|
| Synapsins | 2 | 2014 | 11 | 0.600 |
Why?
|
| Receptors, Opioid, kappa | 6 | 2000 | 37 | 0.590 |
Why?
|
| Benzothiepins | 1 | 2017 | 1 | 0.590 |
Why?
|
| Phosphoproteins | 3 | 2017 | 202 | 0.560 |
Why?
|
| src-Family Kinases | 1 | 2017 | 91 | 0.560 |
Why?
|
| Substance P | 11 | 2007 | 39 | 0.550 |
Why?
|
| Opioid Peptides | 5 | 2010 | 17 | 0.540 |
Why?
|
| Dopamine Agonists | 5 | 2001 | 68 | 0.520 |
Why?
|
| Odorants | 1 | 2015 | 52 | 0.510 |
Why?
|
| Kainic Acid | 13 | 1992 | 44 | 0.510 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2011 | 250 | 0.510 |
Why?
|
| Calcium | 8 | 2022 | 929 | 0.500 |
Why?
|
| Seizures | 14 | 2002 | 279 | 0.500 |
Why?
|
| Analysis of Variance | 11 | 2018 | 1040 | 0.490 |
Why?
|
| Receptors, Muscarinic | 4 | 1999 | 44 | 0.480 |
Why?
|
| Serotonin | 2 | 2012 | 144 | 0.460 |
Why?
|
| Receptor, trkB | 2 | 2011 | 27 | 0.450 |
Why?
|
| Receptors, Dopamine D3 | 2 | 2010 | 12 | 0.450 |
Why?
|
| Dopamine Antagonists | 7 | 2010 | 65 | 0.450 |
Why?
|
| Gene Expression Profiling | 2 | 2008 | 498 | 0.440 |
Why?
|
| Time Factors | 15 | 2013 | 4655 | 0.430 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2013 | 93 | 0.420 |
Why?
|
| MAP Kinase Signaling System | 6 | 2016 | 247 | 0.420 |
Why?
|
| Receptors, Opioid, delta | 3 | 2003 | 37 | 0.400 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2012 | 12 | 0.400 |
Why?
|
| Behavior, Addictive | 3 | 2010 | 317 | 0.400 |
Why?
|
| Down-Regulation | 4 | 2011 | 447 | 0.390 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2008 | 71 | 0.390 |
Why?
|
| Disease Models, Animal | 9 | 2014 | 2550 | 0.380 |
Why?
|
| Microinjections | 6 | 2018 | 130 | 0.370 |
Why?
|
| Extinction, Psychological | 6 | 2018 | 240 | 0.360 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2010 | 12 | 0.360 |
Why?
|
| Brain Chemistry | 5 | 2009 | 173 | 0.360 |
Why?
|
| Cues | 6 | 2018 | 654 | 0.360 |
Why?
|
| Dicarboxylic Acids | 4 | 1999 | 16 | 0.350 |
Why?
|
| Frontal Lobe | 4 | 2010 | 156 | 0.350 |
Why?
|
| Aging | 4 | 2010 | 911 | 0.350 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 196 | 0.350 |
Why?
|
| Extracellular Space | 2 | 2010 | 121 | 0.350 |
Why?
|
| Excitatory Amino Acid Antagonists | 5 | 2001 | 128 | 0.340 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2011 | 331 | 0.340 |
Why?
|
| ras Proteins | 1 | 2010 | 102 | 0.330 |
Why?
|
| Putamen | 3 | 2010 | 35 | 0.330 |
Why?
|
| Thionucleotides | 3 | 2013 | 21 | 0.330 |
Why?
|
| Benzeneacetamides | 2 | 1999 | 11 | 0.330 |
Why?
|
| Basal Ganglia | 3 | 2007 | 45 | 0.320 |
Why?
|
| Minocycline | 1 | 2008 | 61 | 0.310 |
Why?
|
| Baclofen | 2 | 2005 | 24 | 0.310 |
Why?
|
| Neurotransmitter Uptake Inhibitors | 3 | 1999 | 6 | 0.310 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2018 | 1745 | 0.300 |
Why?
|
| Excitatory Amino Acid Agonists | 5 | 2011 | 59 | 0.300 |
Why?
|
| Recurrence | 5 | 2013 | 948 | 0.290 |
Why?
|
| Substance-Related Disorders | 4 | 2013 | 1242 | 0.290 |
Why?
|
| Salicylamides | 5 | 2010 | 18 | 0.280 |
Why?
|
| Neurotoxins | 3 | 2001 | 30 | 0.280 |
Why?
|
| Limbic System | 4 | 1993 | 106 | 0.280 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 2 | 2010 | 16 | 0.270 |
Why?
|
| Immunohistochemistry | 14 | 2010 | 1174 | 0.260 |
Why?
|
| Dopamine D2 Receptor Antagonists | 3 | 2010 | 13 | 0.260 |
Why?
|
| Mice | 12 | 2022 | 8474 | 0.260 |
Why?
|
| Dextroamphetamine | 4 | 1994 | 30 | 0.250 |
Why?
|
| Genes, Immediate-Early | 4 | 2002 | 13 | 0.250 |
Why?
|
| GABA Agonists | 1 | 2005 | 23 | 0.250 |
Why?
|
| Up-Regulation | 4 | 2011 | 682 | 0.250 |
Why?
|
| Conditioning, Operant | 4 | 2017 | 241 | 0.250 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2007 | 208 | 0.250 |
Why?
|
| Colforsin | 2 | 1995 | 42 | 0.250 |
Why?
|
| Naltrexone | 5 | 2000 | 195 | 0.240 |
Why?
|
| GABA-B Receptor Agonists | 1 | 2004 | 5 | 0.240 |
Why?
|
| Receptors, GABA-B | 1 | 2004 | 10 | 0.240 |
Why?
|
| Autoradiography | 5 | 2008 | 94 | 0.240 |
Why?
|
| Blotting, Western | 3 | 2013 | 954 | 0.230 |
Why?
|
| Glycine | 2 | 2011 | 89 | 0.230 |
Why?
|
| Kindling, Neurologic | 5 | 1993 | 24 | 0.230 |
Why?
|
| Receptors, Opioid, mu | 2 | 2003 | 70 | 0.230 |
Why?
|
| Thiazoles | 2 | 2015 | 95 | 0.220 |
Why?
|
| Drug Administration Schedule | 4 | 2010 | 567 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 7 | 2017 | 2791 | 0.220 |
Why?
|
| Genes, fos | 3 | 2008 | 22 | 0.220 |
Why?
|
| Receptors, Opioid | 3 | 1989 | 60 | 0.220 |
Why?
|
| Rats, Inbred Strains | 19 | 1992 | 532 | 0.220 |
Why?
|
| Microdialysis | 6 | 2010 | 147 | 0.220 |
Why?
|
| Muscarinic Antagonists | 4 | 1999 | 54 | 0.220 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 4 | 2011 | 82 | 0.220 |
Why?
|
| Enkephalin, Methionine | 8 | 1988 | 20 | 0.210 |
Why?
|
| Mice, Knockout | 5 | 2010 | 1692 | 0.210 |
Why?
|
| Parvalbumins | 1 | 2022 | 29 | 0.210 |
Why?
|
| Area Under Curve | 3 | 2010 | 238 | 0.210 |
Why?
|
| Receptors, GABA-A | 2 | 2001 | 89 | 0.210 |
Why?
|
| Neurokinin-1 Receptor Antagonists | 1 | 2002 | 2 | 0.210 |
Why?
|
| DNA, Complementary | 1 | 2002 | 251 | 0.210 |
Why?
|
| Acetamides | 1 | 2002 | 17 | 0.200 |
Why?
|
| Caudate Nucleus | 2 | 2000 | 56 | 0.200 |
Why?
|
| CREB-Binding Protein | 2 | 2013 | 10 | 0.200 |
Why?
|
| Colchicine | 6 | 1992 | 48 | 0.200 |
Why?
|
| Synaptic Vesicles | 2 | 2010 | 18 | 0.200 |
Why?
|
| Mice, Transgenic | 3 | 2010 | 1033 | 0.200 |
Why?
|
| Receptor, Metabotropic Glutamate 5 | 3 | 2011 | 51 | 0.190 |
Why?
|
| Signal Transduction | 2 | 2008 | 2689 | 0.190 |
Why?
|
| Muscarinic Agonists | 3 | 1999 | 17 | 0.190 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2001 | 7 | 0.190 |
Why?
|
| Tetrodotoxin | 2 | 2000 | 26 | 0.190 |
Why?
|
| Histocytochemistry | 12 | 2002 | 149 | 0.190 |
Why?
|
| Ethanol | 3 | 2018 | 893 | 0.180 |
Why?
|
| Zinc | 3 | 1990 | 73 | 0.180 |
Why?
|
| Dopamine Agents | 1 | 2000 | 56 | 0.180 |
Why?
|
| Peptides | 3 | 2003 | 455 | 0.170 |
Why?
|
| Receptors, Purinergic P1 | 1 | 1999 | 18 | 0.170 |
Why?
|
| Axons | 2 | 2000 | 139 | 0.170 |
Why?
|
| Receptors, Biogenic Amine | 1 | 1999 | 4 | 0.170 |
Why?
|
| Neurotransmitter Agents | 2 | 1999 | 102 | 0.170 |
Why?
|
| Receptors, Kainic Acid | 3 | 2001 | 24 | 0.170 |
Why?
|
| Cell Shape | 1 | 2018 | 37 | 0.160 |
Why?
|
| Midline Thalamic Nuclei | 1 | 2018 | 3 | 0.160 |
Why?
|
| Clozapine | 1 | 2018 | 46 | 0.160 |
Why?
|
| Cycloleucine | 1 | 1998 | 1 | 0.160 |
Why?
|
| Heterozygote | 2 | 2008 | 174 | 0.160 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2008 | 689 | 0.150 |
Why?
|
| Body Temperature | 2 | 2008 | 116 | 0.150 |
Why?
|
| Secondary Prevention | 2 | 2010 | 291 | 0.150 |
Why?
|
| Sulfonamides | 2 | 2016 | 141 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2000 | 411 | 0.150 |
Why?
|
| Spinal Cord Injuries | 3 | 2001 | 551 | 0.150 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 498 | 0.150 |
Why?
|
| Nerve Endings | 3 | 1999 | 14 | 0.140 |
Why?
|
| Cell Count | 2 | 2008 | 248 | 0.140 |
Why?
|
| Stereotyped Behavior | 3 | 2010 | 42 | 0.140 |
Why?
|
| Motivation | 2 | 2011 | 561 | 0.140 |
Why?
|
| Microglia | 2 | 2008 | 143 | 0.140 |
Why?
|
| Alcoholism | 2 | 2018 | 1109 | 0.140 |
Why?
|
| Benzoates | 1 | 1996 | 20 | 0.140 |
Why?
|
| Drug Interactions | 2 | 2010 | 289 | 0.140 |
Why?
|
| Peptide Fragments | 7 | 2003 | 483 | 0.140 |
Why?
|
| Food Service, Hospital | 1 | 2016 | 2 | 0.140 |
Why?
|
| Binge Drinking | 1 | 2017 | 50 | 0.140 |
Why?
|
| Narcotic Antagonists | 4 | 2003 | 184 | 0.140 |
Why?
|
| Food Services | 1 | 2016 | 13 | 0.140 |
Why?
|
| Phenols | 1 | 2016 | 73 | 0.140 |
Why?
|
| Cell Nucleus | 2 | 1994 | 305 | 0.140 |
Why?
|
| Health Plan Implementation | 1 | 2016 | 37 | 0.130 |
Why?
|
| Piperidines | 1 | 2016 | 123 | 0.130 |
Why?
|
| Nutrition Policy | 1 | 2016 | 44 | 0.130 |
Why?
|
| Pyrimidines | 1 | 2017 | 178 | 0.130 |
Why?
|
| Reward | 2 | 2022 | 201 | 0.130 |
Why?
|
| Guidelines as Topic | 1 | 2016 | 123 | 0.130 |
Why?
|
| Rats, Long-Evans | 6 | 2011 | 203 | 0.130 |
Why?
|
| Excitatory Amino Acids | 1 | 1995 | 8 | 0.130 |
Why?
|
| Amphetamines | 1 | 1995 | 10 | 0.130 |
Why?
|
| Pyridines | 2 | 2011 | 261 | 0.120 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2008 | 134 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 331 | 0.120 |
Why?
|
| Rats, Inbred SHR | 1 | 1994 | 95 | 0.120 |
Why?
|
| Convulsants | 1 | 1993 | 4 | 0.120 |
Why?
|
| Rats, Inbred F344 | 16 | 1992 | 104 | 0.110 |
Why?
|
| Oxotremorine | 3 | 1998 | 6 | 0.110 |
Why?
|
| Epigenomics | 1 | 2013 | 29 | 0.110 |
Why?
|
| Protein Phosphatase 2 | 1 | 2013 | 67 | 0.110 |
Why?
|
| Receptor, IGF Type 2 | 1 | 1992 | 13 | 0.110 |
Why?
|
| Cyclic AMP | 1 | 2013 | 223 | 0.100 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 1992 | 52 | 0.100 |
Why?
|
| Resorcinols | 1 | 2011 | 8 | 0.100 |
Why?
|
| Alcohol Drinking | 1 | 2018 | 805 | 0.100 |
Why?
|
| Zinc Fingers | 3 | 1996 | 17 | 0.100 |
Why?
|
| Reference Values | 4 | 1997 | 579 | 0.100 |
Why?
|
| Hyperkinesis | 1 | 2010 | 8 | 0.090 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 2010 | 21 | 0.090 |
Why?
|
| Oncogene Protein v-akt | 1 | 2010 | 25 | 0.090 |
Why?
|
| Genetic Carrier Screening | 1 | 2010 | 25 | 0.090 |
Why?
|
| Synaptosomes | 3 | 2010 | 57 | 0.090 |
Why?
|
| Bicuculline | 2 | 2001 | 17 | 0.090 |
Why?
|
| Dopaminergic Neurons | 1 | 2010 | 46 | 0.090 |
Why?
|
| GABA Antagonists | 2 | 2001 | 22 | 0.090 |
Why?
|
| Protein Kinase C | 1 | 1991 | 270 | 0.090 |
Why?
|
| Choline O-Acetyltransferase | 2 | 1992 | 30 | 0.090 |
Why?
|
| Statistics as Topic | 1 | 2010 | 219 | 0.090 |
Why?
|
| Silver Staining | 2 | 2008 | 11 | 0.090 |
Why?
|
| Exploratory Behavior | 1 | 2010 | 79 | 0.090 |
Why?
|
| Injections, Intraventricular | 4 | 1995 | 50 | 0.090 |
Why?
|
| Enzyme Inhibitors | 2 | 2006 | 659 | 0.090 |
Why?
|
| Humans | 11 | 2016 | 68618 | 0.090 |
Why?
|
| Central Nervous System Depressants | 1 | 2011 | 182 | 0.090 |
Why?
|
| Memory Disorders | 1 | 2010 | 111 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2010 | 235 | 0.090 |
Why?
|
| Biogenic Monoamines | 1 | 2009 | 18 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 1 | 2010 | 170 | 0.090 |
Why?
|
| Injections | 3 | 1999 | 119 | 0.080 |
Why?
|
| Organ Specificity | 2 | 2002 | 167 | 0.080 |
Why?
|
| Parkinsonian Disorders | 1 | 2009 | 43 | 0.080 |
Why?
|
| Synapses | 3 | 1999 | 222 | 0.080 |
Why?
|
| Memory | 1 | 2010 | 214 | 0.080 |
Why?
|
| Photomicrography | 1 | 2008 | 14 | 0.080 |
Why?
|
| Cell Membrane | 1 | 2010 | 525 | 0.080 |
Why?
|
| Brain Mapping | 2 | 2011 | 532 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 507 | 0.080 |
Why?
|
| Kinetics | 2 | 2002 | 1047 | 0.080 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2008 | 20 | 0.080 |
Why?
|
| Habituation, Psychophysiologic | 1 | 2008 | 22 | 0.080 |
Why?
|
| Neuroanatomy | 1 | 2008 | 14 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2010 | 381 | 0.080 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1988 | 31 | 0.080 |
Why?
|
| Valine | 1 | 1988 | 43 | 0.080 |
Why?
|
| Neurology | 1 | 2008 | 43 | 0.080 |
Why?
|
| Body Weight | 2 | 2010 | 554 | 0.080 |
Why?
|
| Enkephalin, Leucine | 2 | 1986 | 4 | 0.080 |
Why?
|
| Phospholipase C beta | 1 | 2007 | 5 | 0.080 |
Why?
|
| Drug Administration Routes | 1 | 2007 | 25 | 0.070 |
Why?
|
| Dizocilpine Maleate | 2 | 2000 | 43 | 0.070 |
Why?
|
| Hypothalamus, Middle | 2 | 1985 | 4 | 0.070 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 132 | 0.070 |
Why?
|
| Pain | 2 | 2001 | 472 | 0.070 |
Why?
|
| Receptors, Neuropeptide | 1 | 2007 | 22 | 0.070 |
Why?
|
| Radioimmunoassay | 9 | 1988 | 164 | 0.070 |
Why?
|
| Animals, Newborn | 1 | 2007 | 396 | 0.070 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2006 | 7 | 0.070 |
Why?
|
| Aminoacetonitrile | 1 | 2006 | 1 | 0.070 |
Why?
|
| Butadienes | 1 | 2006 | 26 | 0.070 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2006 | 47 | 0.070 |
Why?
|
| Nitriles | 1 | 2006 | 68 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2007 | 167 | 0.070 |
Why?
|
| Blood Vessels | 2 | 1983 | 102 | 0.060 |
Why?
|
| Transcription, Genetic | 3 | 2013 | 562 | 0.060 |
Why?
|
| Grooming | 2 | 2001 | 5 | 0.060 |
Why?
|
| Piperazines | 2 | 1997 | 206 | 0.060 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 2 | 1984 | 15 | 0.060 |
Why?
|
| History, 20th Century | 2 | 2008 | 248 | 0.060 |
Why?
|
| Reinforcement Schedule | 2 | 2014 | 59 | 0.060 |
Why?
|
| Functional Laterality | 2 | 1999 | 240 | 0.060 |
Why?
|
| Quisqualic Acid | 2 | 2001 | 2 | 0.060 |
Why?
|
| Supraoptic Nucleus | 1 | 1983 | 5 | 0.060 |
Why?
|
| Catecholamines | 1 | 1983 | 73 | 0.050 |
Why?
|
| Somatostatin | 1 | 2003 | 36 | 0.050 |
Why?
|
| Spinal Cord | 2 | 2001 | 244 | 0.050 |
Why?
|
| Locus Coeruleus | 1 | 1983 | 55 | 0.050 |
Why?
|
| Sucrose | 1 | 2022 | 58 | 0.050 |
Why?
|
| Age Factors | 1 | 2007 | 1864 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2003 | 152 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 2 | 1994 | 89 | 0.050 |
Why?
|
| Sympathetic Nervous System | 1 | 1982 | 81 | 0.050 |
Why?
|
| Random Allocation | 1 | 2003 | 442 | 0.050 |
Why?
|
| Nerve Growth Factors | 2 | 1992 | 75 | 0.050 |
Why?
|
| Radiographic Image Enhancement | 1 | 2003 | 208 | 0.050 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2001 | 48 | 0.050 |
Why?
|
| Phosphates | 1 | 2001 | 72 | 0.050 |
Why?
|
| Receptors, Glutamate | 1 | 2001 | 22 | 0.050 |
Why?
|
| Injections, Subcutaneous | 1 | 2001 | 87 | 0.050 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 2 | 2011 | 51 | 0.050 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2001 | 56 | 0.050 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 2000 | 6 | 0.040 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2000 | 14 | 0.040 |
Why?
|
| Sodium Channels | 1 | 2000 | 24 | 0.040 |
Why?
|
| Axonal Transport | 1 | 1999 | 9 | 0.040 |
Why?
|
| Depression, Chemical | 1 | 1999 | 29 | 0.040 |
Why?
|
| Receptors, Presynaptic | 1 | 1999 | 6 | 0.040 |
Why?
|
| Sleep | 1 | 2002 | 263 | 0.040 |
Why?
|
| Thoracic Vertebrae | 1 | 2000 | 52 | 0.040 |
Why?
|
| Apomorphine | 4 | 1993 | 48 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2000 | 351 | 0.040 |
Why?
|
| Neuropsychology | 1 | 1999 | 11 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 5 | 1988 | 196 | 0.040 |
Why?
|
| Diffusion | 1 | 1999 | 90 | 0.040 |
Why?
|
| Academies and Institutes | 1 | 1999 | 31 | 0.040 |
Why?
|
| Flavonoids | 1 | 2000 | 109 | 0.040 |
Why?
|
| Haloperidol | 4 | 1993 | 95 | 0.040 |
Why?
|
| Imidazoles | 1 | 2000 | 175 | 0.040 |
Why?
|
| Adenosine | 1 | 1999 | 165 | 0.040 |
Why?
|
| Lumbar Vertebrae | 1 | 2000 | 112 | 0.040 |
Why?
|
| Quinoxalines | 2 | 2001 | 78 | 0.040 |
Why?
|
| Association Learning | 1 | 2018 | 36 | 0.040 |
Why?
|
| Lithium | 2 | 1989 | 76 | 0.040 |
Why?
|
| Tissue Distribution | 5 | 1986 | 282 | 0.040 |
Why?
|
| Female | 8 | 2011 | 38074 | 0.040 |
Why?
|
| Homeostasis | 1 | 1999 | 291 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 3 | 1992 | 95 | 0.040 |
Why?
|
| Globus Pallidus | 1 | 1998 | 64 | 0.040 |
Why?
|
| Perfusion | 1 | 1998 | 131 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2018 | 312 | 0.040 |
Why?
|
| Radionuclide Imaging | 1 | 1997 | 166 | 0.040 |
Why?
|
| Isoquinolines | 1 | 1997 | 37 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1997 | 144 | 0.040 |
Why?
|
| Hypothalamus | 3 | 1986 | 78 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1997 | 146 | 0.030 |
Why?
|
| Acetylcholine | 1 | 1996 | 64 | 0.030 |
Why?
|
| In Vitro Techniques | 3 | 1999 | 765 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 3 | 1988 | 261 | 0.030 |
Why?
|
| Tetrazoles | 1 | 1997 | 160 | 0.030 |
Why?
|
| Gerbillinae | 2 | 1987 | 156 | 0.030 |
Why?
|
| Locomotion | 1 | 2017 | 135 | 0.030 |
Why?
|
| Sulfur Radioisotopes | 1 | 1996 | 11 | 0.030 |
Why?
|
| Sulpiride | 1 | 1996 | 20 | 0.030 |
Why?
|
| Stimulation, Chemical | 1 | 1996 | 57 | 0.030 |
Why?
|
| Electroshock | 5 | 1988 | 36 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 1995 | 61 | 0.030 |
Why?
|
| Workplace | 1 | 2016 | 75 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 1997 | 567 | 0.030 |
Why?
|
| Enkephalin, D-Penicillamine (2,5)- | 2 | 1999 | 7 | 0.030 |
Why?
|
| Nerve Degeneration | 2 | 2001 | 134 | 0.030 |
Why?
|
| N-Methylaspartate | 1 | 1995 | 59 | 0.030 |
Why?
|
| Dietary Sucrose | 1 | 2014 | 18 | 0.030 |
Why?
|
| Rats, Inbred WKY | 1 | 1994 | 48 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2016 | 369 | 0.030 |
Why?
|
| Adenylyl Cyclases | 1 | 1994 | 94 | 0.030 |
Why?
|
| Medulla Oblongata | 2 | 1984 | 19 | 0.030 |
Why?
|
| Uric Acid | 1 | 1993 | 37 | 0.030 |
Why?
|
| Methylation | 1 | 2013 | 56 | 0.030 |
Why?
|
| Naloxone | 3 | 1989 | 56 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 1593 | 0.030 |
Why?
|
| Ferric Compounds | 1 | 1993 | 45 | 0.030 |
Why?
|
| Acetylation | 1 | 2013 | 94 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1992 | 35 | 0.030 |
Why?
|
| Chromatin | 1 | 2013 | 76 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 1994 | 791 | 0.030 |
Why?
|
| Tachykinins | 2 | 1989 | 8 | 0.030 |
Why?
|
| Histones | 1 | 2013 | 111 | 0.030 |
Why?
|
| Glutamates | 1 | 1992 | 41 | 0.030 |
Why?
|
| Carbachol | 1 | 1992 | 34 | 0.030 |
Why?
|
| Brain Tissue Transplantation | 1 | 1991 | 10 | 0.030 |
Why?
|
| Fetal Tissue Transplantation | 1 | 1991 | 12 | 0.030 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 1 | 2011 | 21 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2013 | 240 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2011 | 15 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2011 | 92 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2013 | 193 | 0.020 |
Why?
|
| Immunologic Techniques | 4 | 1986 | 30 | 0.020 |
Why?
|
| Genes, ras | 1 | 2011 | 46 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2011 | 43 | 0.020 |
Why?
|
| Dipeptides | 1 | 1991 | 89 | 0.020 |
Why?
|
| Nerve Fibers | 1 | 1991 | 77 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 2010 | 48 | 0.020 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2010 | 9 | 0.020 |
Why?
|
| Pyramidal Cells | 1 | 1991 | 79 | 0.020 |
Why?
|
| Epilepsy | 2 | 1987 | 336 | 0.020 |
Why?
|
| Base Sequence | 1 | 1992 | 1015 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2011 | 74 | 0.020 |
Why?
|
| Allosteric Regulation | 1 | 2010 | 58 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2011 | 218 | 0.020 |
Why?
|
| Potassium | 1 | 2010 | 168 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1992 | 1447 | 0.020 |
Why?
|
| Actins | 1 | 2011 | 249 | 0.020 |
Why?
|
| Postural Balance | 1 | 2010 | 93 | 0.020 |
Why?
|
| Learning | 1 | 1991 | 186 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 710 | 0.020 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 2009 | 40 | 0.020 |
Why?
|
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 1989 | 5 | 0.020 |
Why?
|
| Quinolines | 1 | 1989 | 48 | 0.020 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 1988 | 27 | 0.020 |
Why?
|
| Toluene | 1 | 1989 | 37 | 0.020 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 1988 | 9 | 0.020 |
Why?
|
| Cerebellum | 1 | 1989 | 103 | 0.020 |
Why?
|
| Granulocytes | 1 | 1988 | 22 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2008 | 127 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2013 | 447 | 0.020 |
Why?
|
| Drug Synergism | 1 | 1988 | 260 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2016 | 2800 | 0.020 |
Why?
|
| Electrophysiology | 1 | 1988 | 160 | 0.020 |
Why?
|
| Analgesics | 1 | 1988 | 118 | 0.020 |
Why?
|
| Brain Stem | 1 | 1986 | 46 | 0.020 |
Why?
|
| Staining and Labeling | 2 | 1983 | 144 | 0.020 |
Why?
|
| Cross Reactions | 2 | 1983 | 57 | 0.020 |
Why?
|
| Cell Survival | 1 | 1989 | 901 | 0.020 |
Why?
|
| Septal Nuclei | 1 | 1986 | 31 | 0.020 |
Why?
|
| Models, Biological | 1 | 2009 | 981 | 0.020 |
Why?
|
| Olfactory Pathways | 1 | 1985 | 9 | 0.020 |
Why?
|
| Dexamethasone | 1 | 1985 | 150 | 0.020 |
Why?
|
| Estradiol | 1 | 1985 | 176 | 0.020 |
Why?
|
| Olfactory Bulb | 1 | 1984 | 14 | 0.010 |
Why?
|
| Thalamic Nuclei | 1 | 1983 | 9 | 0.010 |
Why?
|
| Melanocyte-Stimulating Hormones | 1 | 1983 | 3 | 0.010 |
Why?
|
| Rabbits | 2 | 2001 | 509 | 0.010 |
Why?
|
| United States | 1 | 2016 | 7367 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1983 | 106 | 0.010 |
Why?
|
| Vasopressins | 1 | 1983 | 33 | 0.010 |
Why?
|
| Nephropidae | 1 | 1981 | 2 | 0.010 |
Why?
|
| Fluorescence | 1 | 1982 | 104 | 0.010 |
Why?
|
| Visual Pathways | 1 | 1981 | 31 | 0.010 |
Why?
|
| Urine | 1 | 2001 | 47 | 0.010 |
Why?
|
| Indans | 1 | 2001 | 20 | 0.010 |
Why?
|
| Chlorides | 2 | 1993 | 68 | 0.010 |
Why?
|
| Feces | 1 | 2001 | 88 | 0.010 |
Why?
|
| Probability | 1 | 2001 | 245 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 2001 | 187 | 0.010 |
Why?
|
| 4-Aminopyridine | 1 | 1999 | 5 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 1999 | 29 | 0.010 |
Why?
|
| Potassium Channel Blockers | 1 | 1999 | 32 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2001 | 328 | 0.010 |
Why?
|
| Chelating Agents | 1 | 1999 | 47 | 0.010 |
Why?
|
| Potassium Channels | 1 | 1999 | 55 | 0.010 |
Why?
|
| Neurokinin A | 2 | 1989 | 5 | 0.010 |
Why?
|
| Pyramidal Tracts | 2 | 1992 | 45 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 1753 | 0.010 |
Why?
|
| Electric Stimulation | 2 | 1989 | 218 | 0.010 |
Why?
|
| Immunochemistry | 2 | 1986 | 17 | 0.010 |
Why?
|
| Heart | 1 | 2001 | 850 | 0.010 |
Why?
|
| Lung | 1 | 2001 | 849 | 0.010 |
Why?
|
| Afferent Pathways | 2 | 1984 | 31 | 0.010 |
Why?
|
| Ascorbic Acid | 1 | 1993 | 45 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1993 | 124 | 0.010 |
Why?
|
| Mesencephalon | 1 | 1993 | 41 | 0.010 |
Why?
|
| Cell Death | 1 | 1993 | 329 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1992 | 47 | 0.010 |
Why?
|
| Acetylcholinesterase | 1 | 1992 | 19 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 1992 | 40 | 0.010 |
Why?
|
| Exocytosis | 1 | 1992 | 34 | 0.010 |
Why?
|
| Tremor | 1 | 1991 | 16 | 0.010 |
Why?
|
| Movement | 1 | 1991 | 179 | 0.010 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 1990 | 15 | 0.010 |
Why?
|
| Hydroxydopamines | 1 | 1990 | 25 | 0.010 |
Why?
|
| Ergolines | 1 | 1990 | 19 | 0.010 |
Why?
|
| Oxidopamine | 1 | 1990 | 42 | 0.010 |
Why?
|
| Quinpirole | 1 | 1990 | 26 | 0.010 |
Why?
|
| Electroencephalography | 2 | 1983 | 418 | 0.010 |
Why?
|
| Lithium Chloride | 1 | 1988 | 10 | 0.000 |
Why?
|
| Lithium Carbonate | 1 | 1988 | 31 | 0.000 |
Why?
|
| Genes | 1 | 1988 | 86 | 0.000 |
Why?
|
| Organ Size | 1 | 1988 | 242 | 0.000 |
Why?
|
| Adrenalectomy | 1 | 1985 | 17 | 0.000 |
Why?
|
| beta-Endorphin | 1 | 1985 | 15 | 0.000 |
Why?
|
| Ovariectomy | 1 | 1985 | 49 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1985 | 62 | 0.000 |
Why?
|
| Chemistry | 1 | 1985 | 45 | 0.000 |
Why?
|
| Hypothalamus, Posterior | 1 | 1984 | 6 | 0.000 |
Why?
|
| Protein Biosynthesis | 1 | 1985 | 181 | 0.000 |
Why?
|
| Hypothalamic Area, Lateral | 1 | 1984 | 17 | 0.000 |
Why?
|
| Horseradish Peroxidase | 1 | 1983 | 27 | 0.000 |
Why?
|
| Cerebral Ventricles | 1 | 1984 | 36 | 0.000 |
Why?
|
| Peripheral Nerves | 1 | 1983 | 22 | 0.000 |
Why?
|
| Electric Conductivity | 1 | 1983 | 87 | 0.000 |
Why?
|
| Vagus Nerve | 1 | 1984 | 90 | 0.000 |
Why?
|
| Efferent Pathways | 1 | 1982 | 15 | 0.000 |
Why?
|
| Nervous System | 1 | 1983 | 45 | 0.000 |
Why?
|
| Immunoassay | 1 | 1983 | 64 | 0.000 |
Why?
|
| Species Specificity | 1 | 1983 | 303 | 0.000 |
Why?
|
| Neural Inhibition | 1 | 1983 | 80 | 0.000 |
Why?
|
| Biomechanical Phenomena | 1 | 1983 | 368 | 0.000 |
Why?
|
| Magnesium | 1 | 1982 | 110 | 0.000 |
Why?
|
| Retina | 1 | 1981 | 252 | 0.000 |
Why?
|